CERo Therapeutics Holdings Inc CERO
Trading Information
- Previous Close Price
- $0.01
- Day Range
- $0.01–0.01
- 52-Week Range
- $0.01–4.40
- Bid/Ask
- $0.01 / $0.01
- Shares Outstanding
- 71.63M
- Market Cap
- $372,699.20
- Volume/Avg
- 1M / 610,798
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
CERo Therapeutics Holdings Inc is an immunotherapy company advancing the development of next-generation engineered T cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, which enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, is designed to engage the body's full immune repertoire to achieve optimized cancer therapy. The company's molecule is CER-1236, an autologous T-cell product that targets a novel tumor antigen, TIM-4 ligand.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- —
- Total Number of Employees
- 8
- Website
- https://www.cero.bio
Valuation
|
Metric
|
CERO
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
CERO
|
|---|---|
Quick Ratio | 0.03 |
Current Ratio | 0.05 |
Interest Coverage | −18.07 |
Quick Ratio
CERO
Profitability
|
Metric
|
CERO
|
|---|---|
Return on Assets (Normalized) | −235.11% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
CERO
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|#%BrhL | LOCK|^^SQ | $129B | |||
| Moderna Inc
MRNA
| LOCK|?v@Zj<K | LOCK|j$ | $90B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|!X^b>r | LOCK|wh<L | $77B | |||
| argenx SE ADR
ARGX
| LOCK|ps&kVC | LOCK|slD | $51B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|Zv%$>$ | LOCK|LjB | $41B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|g<Dy!s# | LOCK|dr<@ | $31B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|f%t>!F& | LOCK|CdsZl | $25B | |||
| BioNTech SE ADR
BNTX
| LOCK|WljqqH& | LOCK|&B! | $24B | |||
| Incyte Corp
INCY
| LOCK|hsyyHy | LOCK|B<< | $23B | |||
| Jazz Pharmaceuticals PLC
JAZZ
| LOCK|z#$y#@$ | LOCK|B!b | $14B |
United States